Cearvol Wave vs Otofonix Groove

The Cearvol Wave is a budget-priced OTC hearing aid with a visible in-ear style, earning a B grade with a SoundScore of 3.9/5 in our lab testing. At $397, it ranks #22 among 65 OTC hearing aids tested, placing it in the top 32% of its category. The Wave's standout performance is in music streaming, where it scores a strong 4.1/5—a full 2.18 points above the OTC category average. This makes it an unusually capable choice for users who prioritize audio entertainment alongside speech amplification. Speech performance is solid in quiet environments at 3.1/5, sitting 0.36 points above the category average. Speech in noise presents a more mixed picture: while the 2.0/5 score exceeds the category average by 0.56 points, it remains modest in absolute terms—typical of OTC devices without advanced noise management. Own-voice comfort scores 2.1/5, falling 0.41 points below average, which may be noticeable during extended wear. Feedback handling is solid at 3.8/5, though 0.74 points below the category average. The Cearvol Wave is best suited for budget-conscious consumers who want capable music streaming and adequate speech clarity in quieter settings. Those frequently in noisy environments or sensitive to own-voice quality may want to consider alternatives with stronger performance in those areas.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE device ranks 36th out of 36 tested prescription hearing aids, placing it in the bottom tier of its category. In our testing, the Groove demonstrated one clear strength: excellent feedback handling at 5.0/5, scoring 0.29 points above the category average. The device remained stable during our standardized challenge motions with no audible feedback issues. However, speech performance was significantly limited, with both speech in quiet and speech in noise scoring 1.0/5—falling 2.32 and 0.96 points below their respective category averages. Music streaming quality scored 0.0/5, which is 2.64 points below the prescription category average. Own-voice comfort was also low at 0.4/5 in the tuned configuration, 2.35 points below average, suggesting notable occlusion-related concerns. The normalized Initial Score of 2.7/5 and Tuned Score of 2.6/5 indicate that professional fitting adjustments did not improve overall performance. Given its positioning at the bottom of the prescription hearing aid category and the availability of lower-priced alternatives that scored higher in our testing, the Otofonix Groove may be difficult to recommend for most users seeking balanced sound quality across listening situations.